Map and Requirements‎ > ‎FAQs‎ > ‎

CDC and BioSense 2.0

How is BioSense 2.0 funded?

BioSense 2.0 is funded through annual federal appropriation to the CDC.  In 2012, $7 million in BioSense funding was allocated to state and local jurisdictions through the BioSense Program's Cooperative Agreement.


What happens if states/locals go to the cloud to take advantage of the potential financial savings by not having to maintain their own systems, and CDC decides not to fund the local system any longer? Or asks states to pay into the cloud?

CDC is committed to supporting the nation’s public health surveillance infrastructure, and believes that state and local health departments are the foundation of that infrastructure. While every effort will be made to maintain financial support for the distributed data model for public health surveillance, it is impossible to predict future budgets or the future cost to maintain the BioSense 2.0 cloud environment.  Further, CDC and the BioSense 2.0 team are happy to work with current surveillance systems as well as all types of data aggregators at the jurisdiction’s discretion, and it is not CDC’s intention to dismantle any systems already in place. 


Does CDC provide any funding for states and localities that participate in BioSense 2.0?

In 2012, the BioSense Program issued its first grant, awarding $7M to 35 jurisdictions in order to assist in the implementation of BioSense 2.0 and further the practice of syndromic surveillance.  Please refer to the CDC site for information of other funding opportunities in the future.  FAQs specific to the current grant can be found here.


How will CDC use the data we contribute to BioSense 2.0?

The Centers for Disease Control and Prevention is a large organization of centers that focus on understanding and preventing infectious, chronic, workplace, and environmental diseases and injuries. Each center will benefit from more timely and representative population health information. At a minimum, CDC will use BioSense 2.0 data help guide regional or national policy and program management decisions. Sharing BioSense 2.0 data with CDC will in no way change the collaborative relationship CDC maintains with states, wherein state and local jurisdictions speak for their population's status of health. Jurisdictions will ultimately have control of what data are shared with partners, including CDC. CDC will use the information to help provide regional or national picture for all-hazards. Under the new arrangement, CDC is one of several participants in the governance of BioSense 2.0.


If a copy of my state’s data is downloaded to CDC for analysis, it could be subject to FOIA requests. This will be problematic for policymakers in my state. Will CDC be able to do analyses with data in the cloud without downloading it?

With the BioSense sharing model, users can define how and what type of access CDC will have to analyze and receive data. All data/information that external organizations provide to CDC or other federal agencies is subject to the Freedom of Information Act (FOIA) requirements.

Data shared with CDC for analysis using BioSense 2.0 are no exception. Jurisdictions will ultimately have control of what data are shared with partners including CDC, and should always consider FOIA and open records laws when they determine what and how much data they share.